Canada: Enrollment Concluded

On November 2, 2015, enrollment was concluded in our study of MDMA-assisted psychotherapy for PTSD from sexual assault, violent crime, military service, or any other cause, taking place in Vancouver, Canada. This small pilot study gave Canadian therapists experience with a MAPS-sponsored Phase 2 clinical trial of MDMA-assisted psychotherapy for PTSD, with data collected from three women and three men. All participants have completed treatments and are in long-term follow-up. The final results will be prepared for publication in 2016 as a part of a global meta-analysis of MDMA-assisted psychotherapy results.